Anesthesiologist Michael S. Avidan, MBBCh, reproductive biologist Sarah K. England, PhD, and neurologist Timothy Miller, MD, PhD, all of Washington University School of Medicine in St. Louis, have been elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine in the United States.
This program was developed to address structural barriers that impede successful advancement and promotion of historically marginalized research faculty within the academic medicine academy.
Share:
U.S. FDA Granted Fast Track Designation in 2018
Trial Expected to Enroll 300-400 Patients at Approximately 165 Sites in the U.S. and Europe in Simplified Adaptive Trial Design
Conference Call and Webcast Today at 8:30 a.m. ET
HOUSTON, April 27, 2021 (GLOBE NEWSWIRE) Aravive Inc. (NASDAQ:ARAV), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, today announced the Company has dosed the first patient in its Phase 3 trial of AVB-500 in platinum resistant ovarian cancer (PROC). The trial is evaluating the efficacy of AVB-500 in combination with paclitaxel (chemotherapy) and the primary endpoint is progression free survival.
January 15, 2021 SHARE Researchers at Washington University School of Medicine have received a $791,317 grant from the National Institutes of Health (NIH) to study factors that keep pregnant women from getting tested for COVID-19, to evaluate whether it is important to test women regularly during their pregnancies, and to determine whether pregnant women with COVID-19 need more specialized prenatal care. (Photo: Getty Images)
Pregnant women with COVID-19 face an increased risk of complications from the illness, including preterm birth, delivery by cesarean section, and, compared with other women of the same age, higher likelihood of death or admission to an intensive care unit.